Humana (HUM) – Investment Analysts’ Weekly Ratings Changes

Humana (NYSE: HUM) has recently received a number of price target changes and ratings updates:

• 10/13/2026 – Humana had its price target raised by Mizuho from $468.00 to $495.00. They now have an “outperform” rating on the stock.
• 10/12/2026 – Humana had its price target raised by Oppenheimer Holdings, Inc. from $475.00 to $525.00. They now have an “outperform” rating on the stock.
• 10/12/2026 – Humana had its price target raised by UBS Group AG from $405.00 to $495.00. They now have a “neutral” rating on the stock.
• 10/12/2026 – Humana had its price target raised by Truist Financial Corporation from $415.00 to $475.00. They now have a “hold” rating on the stock.
• 10/12/2026 – Humana was upgraded by Raymond James Financial, Inc. from “market perform” to “outperform”. They now have a $520.00 price target on the stock.
• 10/9/2026 – Humana was upgraded by Morgan Stanley from “underweight” to “overweight”.
• 10/9/2026 – Humana was upgraded by Monness Crespi & Hardt to “buy”.
• 10/9/2026 – Humana is now covered by Citigroup Inc.. They set a “buy” rating on the stock.
• 10/9/2026 – Humana had its price target raised by Oppenheimer Holdings, Inc. from $405.00 to $475.00. They now have an “outperform” rating on the stock.
• 10/9/2026 – Humana had its price target raised by Barclays PLC from $515.00 to $582.00. They now have an “overweight” rating on the stock.
• 10/9/2026 – Humana was given a new $596.00 price target by UBS Group AG.
• 10/9/2026 – Humana was given a new $596.00 price target by Robert W. Baird. They now have an “outperform” rating on the stock.
• 10/9/2026 – Humana was upgraded by Robert W. Baird from “neutral” to “outperform”. They now have a $596.00 price target on the stock, up from $390.00.
• 10/7/2026 – Humana was given a new $460.00 price target by Raymond James Financial, Inc..
• 10/7/2026 – Humana was upgraded by Cantor Fitzgerald from “neutral” to “overweight”. They now have a $460.00 price target on the stock, up from $300.00.
• 9/27/2026 – Humana was downgraded by Wall Street Zen from “buy” to “hold”.
• 9/25/2026 – Humana was upgraded by Barclays PLC from “equal weight” to “overweight”. They now have a $515.00 price target on the stock, up from $407.00.
• 9/19/2026 – Humana was upgraded by Wall Street Zen from “hold” to “buy”.
• 9/4/2026 – Humana had its “neutral” rating reaffirmed by Cantor Fitzgerald.
• 8/24/2026 – Humana had its “outperform” rating reaffirmed by Wolfe Research. They now have a $450.00 price target on the stock.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be given a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, October 30th. Humana’s dividend payout ratio is 33.49%.

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.